Haploinsufficiency of Flap endonuclease ( <i>Fen1</i> ) leads to rapid tumor progression

Melanie H. Kucherlapati(Cancer Genetics (United States)), Kan Yang(Cancer Genetics (United States)), Mari Kuraguchi(Cancer Genetics (United States)), Jie Zhao(Cancer Genetics (United States)), Maria Lia(Cancer Genetics (United States)), Joerg Heyer(Cancer Genetics (United States)), Michael Kane(Cancer Genetics (United States)), Kunhua Fan(Cancer Genetics (United States)), Robert G. Russell(Cancer Genetics (United States)), Anthony M. Brown(Cornell University), Burkhard Kneitz(Cancer Genetics (United States)), Winfried Edelmann(Cancer Genetics (United States)), Richard D. Kolodner(Cancer Genetics (United States)), Martin Lipkin(Cancer Genetics (United States)), Raju Kucherlapati(Cancer Genetics (United States))
Proceedings of the National Academy of Sciences
July 15, 2002
Cited by 236Open Access
Full Text

Abstract

Flap endonuclease (Fen1) is required for DNA replication and repair, and defects in the gene encoding Fen1 cause increased accumulation of mutations and genome rearrangements. Because mutations in some genes involved in these processes cause cancer predisposition, we investigated the possibility that Fen1 may function in tumorigenesis of the gastrointestinal tract. Using gene knockout approaches, we introduced a null mutation into murine Fen1. Mice homozygous for the Fen1 mutation were not obtained, suggesting absence of Fen1 expression leads to embryonic lethality. Most Fen1 heterozygous animals appear normal. However, when combined with a mutation in the adenomatous polyposis coli (Apc) gene, double heterozygous animals have increased numbers of adenocarcinomas and decreased survival. The tumors from these mice show microsatellite instability. Because one copy of the Fen1 gene remained intact in tumors, Fen1 haploinsufficiency appears to lead to rapid progression of cancer.


Related Papers

No related papers found

Powered by citation graph analysis